BMJ Evidence-Based Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 10.8 | Q1 | 95.8% | 2.245 | Q1 | 96.2% |
| 2024 | 7.6 | Q1 | 94.3% | 1.800 | Q1 | 94.3% |
| 2023 | 9.0 | Q1 | 95.1% | 1.317 | Q1 | 90.9% |
| 2022 | 5.8 | Q1 | 89.4% | 1.344 | Q1 | 91.6% |
| 2021 | 4.7 | Q2 | 84.8% | 1.202 | Q1 | 90.0% |
| 2020 | — | — | 0.676 | Q2 | 75.2% | |
| 2019 | — | — | 0.870 | Q1 | 82.4% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF